Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nonalcoholic Steatohepatitis With Liver Fibrosis”

172 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 172 results

Large-scale testing (Phase 3)Active Not RecruitingNCT03900429
What this trial is testing

Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Madrigal Pharmaceuticals, Inc. 1,759
Large-scale testing (Phase 3)Active Not RecruitingNCT04951219
What this trial is testing

Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Madrigal Pharmaceuticals, Inc. 810
Not applicableNot Yet RecruitingNCT07797101
What this trial is testing

Body-weight Reduction Effect on Portal Hypertension in Compensated Cirrhosis

Who this might be right for
CirrhosisPortal HypertensionFatty Liver Disease+1 more
The Second Affiliated Hospital of Chongqing Medical University 50
Testing effectiveness (Phase 2)Looking for participantsNCT07481734
What this trial is testing

Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)

Who this might be right for
Metabolic Associated Steatotic Liver DiseaseNonalcoholic SteatohepatitisHepatic Steatosis
Hudson Biotech 120
Testing effectiveness (Phase 2)Study completedNCT03656068
What this trial is testing

An Evaluation of the Safety and Efficacy of Nitazoxanide on Collagen Turnover in NASH Patients With Fibrosis

Who this might be right for
Non-alcoholic SteatohepatitisFatty LiverFibrosis, Liver+1 more
Pinnacle Clinical Research, PLLC 21
Testing effectiveness (Phase 2)Study completedNCT03517540
What this trial is testing

Study of Safety, Tolerability, and Efficacy of a Combination Treatment of LJN452 and CVC in Adult Patients With NASH and Liver Fibrosis

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
Novartis Pharmaceuticals 193
Large-scale testing (Phase 3)Ended earlyNCT03028740
What this trial is testing

AURORA: A Study for the Efficacy and Safety of Cenicriviroc (CVC) for the Treatment of Liver Fibrosis in Adults With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis
Tobira Therapeutics, Inc. 1,778
Large-scale testing (Phase 3)Looking for participantsNCT06461208
What this trial is testing

A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis

Who this might be right for
Liver Cirrhosis
King's College London 300
Not applicableUnknownNCT03525769
What this trial is testing

Screening With FibroTouch for Advanced Liver Fibrosis in NAFLD Patients With Underlying Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusNonalcoholic Fatty Liver Disease (NAFLD)
Nanfang Hospital, Southern Medical University 10,000
Early research (Phase 1)Study completedNCT04857437
What this trial is testing

Study in Healthy Adults Evaluating PF-07202954

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseLiver Fibrosis
Pfizer 12
Testing effectiveness (Phase 2)Study completedNCT02854605
What this trial is testing

Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Gilead Sciences 140
Not applicableWithdrawnNCT01987310
What this trial is testing

Assessment of Endothelial Function in Patients With Non Alcoholic Fatty Liver Disease and the Impact of Statin Treatment

Who this might be right for
Non Alcoholic Fatty Liver Disease
Sheba Medical Center
Large-scale testing (Phase 3)Ended earlyNCT03053050
What this trial is testing

Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis

Who this might be right for
Nonalcoholic Steatohepatitis
Gilead Sciences 808
Not applicableStudy completedNCT01874249
What this trial is testing

Non Invasive Assessment of Liver Fibrosis in Fatty Liver Disease

Who this might be right for
Non Alcoholic Fatty Liver Disease
Fundación Clínica Médica Sur 1,200
Early research (Phase 1)Ended earlyNCT05604287
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of ID119031166M With the Exploration of Pharmacodynamic Effects

Who this might be right for
Healthy Participants
IlDong Pharmaceutical Co Ltd 67
Not applicableEnded earlyNCT03479125
What this trial is testing

Post-Treatment Follow-up Study for Liver Disease Subjects With or Without Cirrhosis After Receiving Emricasan or Placebo

Who this might be right for
Liver DiseasesLiver FibrosisLiver Cirrhosis+3 more
Conatus Pharmaceuticals Inc. 40
Not applicableStudy completedNCT04241575
What this trial is testing

Identification of Fatty Liver With Advanced Fibrosis in Type 2 Diabetes Using Simple Fibrosis Scores and Electronic Reminder Messages

Who this might be right for
Fatty Liver, NonalcoholicDiabetes Mellitus, Type 2
Chinese University of Hong Kong 1,061
Large-scale testing (Phase 3)Study completedNCT02030977
What this trial is testing

The Effects of Resveratrol Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis

Who this might be right for
Non Alcoholic Fatty Liver
Dr Azita Hekmatdoost 50
Early research (Phase 1)Study completedNCT04643795
What this trial is testing

Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses of MGL-3196 in Subjects With Varying Degrees of Hepatic Impairment and Healthy Matched Control Subjects

Who this might be right for
Hepatic ImpairmentNASH - Nonalcoholic SteatohepatitisCirrhosis, Liver
Madrigal Pharmaceuticals, Inc. 87
Not applicableLooking for participantsNCT04366999
What this trial is testing

Effectiveness of Bariatric Surgery for NAFLD/NASH

Who this might be right for
Bariatric Surgery CandidateNAFLDNASH With Fibrosis
Beijing Friendship Hospital 320
Next Page